<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: pharmaceutical giant</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Drug maker Novartis loses India patent battle (Update)</title>
   	 <description>India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines.</description>
     <link>http://medicalxpress.com/news/2013-04-drug-maker-india-patent.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 01 Apr 2013 04:28:55 EST</pubDate>
	 <guid isPermaLink="false">news284009309</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/drugmakerlos.jpg" width="90" height="90" />
</item>
<item>
     <title>Niacin therapy unhelpful, occasionally harmful, study says</title>
   	 <description>A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.</description>
     <link>http://medicalxpress.com/news/2013-03-niacin-therapy-unhelpful-occasionally.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sat, 09 Mar 2013 15:11:35 EST</pubDate>
	 <guid isPermaLink="false">news282064288</guid>
	 
</item>
<item>
     <title>Top US court allows Amgen class action suit</title>
   	 <description>The US Supreme Court ruled Wednesday in favor of investors seeking to join a class-action lawsuit against pharmaceutical giant Amgen for downplaying safety concerns about two anemia drugs.</description>
     <link>http://medicalxpress.com/news/2013-02-court-amgen-class-action.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 28 Feb 2013 05:00:01 EST</pubDate>
	 <guid isPermaLink="false">news281248021</guid>
	 
</item>
<item>
     <title>Italy lifts ban on Novartis flu vaccines</title>
   	 <description>Italian health authorities on Friday lifted a ban on the sale of flu vaccines made by Swiss pharmaceutical giant Novartis, saying that tests had shown they were not a health risk.</description>
     <link>http://medicalxpress.com/news/2012-11-italy-novartis-flu-vaccines.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 09 Nov 2012 08:26:14 EST</pubDate>
	 <guid isPermaLink="false">news271671963</guid>
	 
</item>
<item>
     <title>Canada high court voids Pfizer's Viagra patent</title>
   	 <description>Canada's top court on Thursday stripped Pfizer of its patent for Viagra, saying the pharmaceutical giant failed in the patent to identify the active compound in the drug.</description>
     <link>http://medicalxpress.com/news/2012-11-canada-high-court-voids-pfizer.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 08 Nov 2012 15:09:56 EST</pubDate>
	 <guid isPermaLink="false">news271609777</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/viagra.jpg" width="90" height="59" />
</item>
<item>
     <title>Italy, Switzerland, Austria freeze sales of Novartis flu vaccines</title>
   	 <description>Italian, Swiss and Austrian authorities on Wednesday halted the sale of flu vaccines made by Swiss pharmaceutical giant Novartis.</description>
     <link>http://medicalxpress.com/news/2012-10-italy-switzerland-austria-sales-novartis.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 24 Oct 2012 15:50:23 EST</pubDate>
	 <guid isPermaLink="false">news270312606</guid>
	 
</item>
<item>
     <title>Merck partnership accelerates needle-free vaccine delivery</title>
   	 <description>A University of Queensland invention that will deliver vaccines without the need for needles has struck a significant partnership with US-based pharmaceutical giant Merck, announced today. </description>
     <link>http://medicalxpress.com/news/2012-10-merck-partnership-needle-free-vaccine-delivery.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 09 Oct 2012 09:08:50 EST</pubDate>
	 <guid isPermaLink="false">news268992521</guid>
	 
</item>
<item>
     <title>Bayer 'disappointed' after losing India patent fight</title>
   	 <description> Pharmaceutical giant Bayer AG on Wednesday said it was &quot;disappointed&quot; with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and lung cancer.</description>
     <link>http://medicalxpress.com/news/2012-09-bayer-disappointed-india-patent.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 26 Sep 2012 09:34:52 EST</pubDate>
	 <guid isPermaLink="false">news267870881</guid>
	 
</item>
<item>
     <title>Roche probed over faulty drug-safety reporting</title>
   	 <description> Swiss pharmaceutical giant Roche is under investigation over a failure to properly report adverse drug side-effects, the European Medicines Agency (EMA) said on Thursday.</description>
     <link>http://medicalxpress.com/news/2012-06-roche-probed-faulty-drug-safety.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 21 Jun 2012 17:02:17 EST</pubDate>
	 <guid isPermaLink="false">news259516928</guid>
	 
</item>
<item>
     <title>Drug cocktail boosts ovarian cancer survival time</title>
   	 <description> A drug cocktail that combines chemotherapy with Avastin was shown to double the amount of time patients lived without progression of ovarian cancer, according to research released Saturday.</description>
     <link>http://medicalxpress.com/news/2012-06-drug-cocktail-boosts-ovarian-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 02 Jun 2012 13:23:52 EST</pubDate>
	 <guid isPermaLink="false">news257862174</guid>
	 
</item>
<item>
     <title>Sanofi teams up with India to make cheap ARVs in S.Africa</title>
   	 <description> French pharmaceutical giant Sanofi has signed a partnership with India's Hetero to manufacture cheap anti-HIV drugs in South Africa, the company said on Friday.</description>
     <link>http://medicalxpress.com/news/2012-03-sanofi-teams-india-cheap-arvs.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 30 Mar 2012 13:16:27 EST</pubDate>
	 <guid isPermaLink="false">news252332179</guid>
	 
</item>
<item>
     <title>Merck blood thinner shows mixed results: study</title>
   	 <description> An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers said Saturday.</description>
     <link>http://medicalxpress.com/news/2012-03-merck-blood-thinner-results.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sat, 24 Mar 2012 19:12:54 EST</pubDate>
	 <guid isPermaLink="false">news251835164</guid>
	 
</item>
<item>
     <title>Alzheimer's drug sharply criticized by medical experts</title>
   	 <description>Watching Alzheimer's disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. But a new pill formulated by a respected pharmaceutical company and approved by the Food and Drug Administration will do little to help most patients and bring misery to some, say two medical investigators.</description>
     <link>http://medicalxpress.com/news/2012-03-alzheimer-drug-sharply-criticized-medical.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Fri, 23 Mar 2012 10:50:01 EST</pubDate>
	 <guid isPermaLink="false">news251717731</guid>
	 
</item>
<item>
     <title>Bayer mulls challenge to India cancer drug ruling</title>
   	 <description> Bayer AG said Tuesday it was mulling ways to challenge a ground-breaking Indian ruling allowing a local firm to produce a vastly cheaper copy of a cancer drug made by the German pharmaceutical giant.</description>
     <link>http://medicalxpress.com/news/2012-03-bayer-mulls-india-cancer-drug.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 13 Mar 2012 11:13:26 EST</pubDate>
	 <guid isPermaLink="false">news250856001</guid>
	 
</item>
<item>
     <title>Effects of Tamiflu still uncertain, warn experts, as Roche continues to withhold key trial data</title>
   	 <description>Two years after pharmaceutical giant Roche promised the BMJ it would release key Tamiflu trial data for independent scrutiny, the safety and effectiveness of this anti-influenza drug remains uncertain, warn experts today.</description>
     <link>http://medicalxpress.com/news/2012-01-effects-tamiflu-uncertain-experts-roche.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 18 Jan 2012 04:10:01 EST</pubDate>
	 <guid isPermaLink="false">news246081006</guid>
	 
</item>
<item>
     <title>Bristol-Myers Squibb to buy Inhibitex for $2.5 billion</title>
   	 <description> Pharmaceutical giant Bristol-Myers Squibb Company announced it was acquiring Inhibitex, Inc., a company specializing in treatment of hepatitis C, for $2.5 billion (1.9 billion euros).</description>
     <link>http://medicalxpress.com/news/2012-01-bristol-myers-squibb-inhibitex-billion.html</link>
	 <category>Medications</category>
	 <pubDate>Sun, 08 Jan 2012 06:59:59 EST</pubDate>
	 <guid isPermaLink="false">news245228187</guid>
	 
</item>
<item>
     <title>US approves India's Ranbaxy to make generic Lipitor</title>
   	 <description> Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.</description>
     <link>http://medicalxpress.com/news/2011-12-india-ranbaxy-lipitor.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 01 Dec 2011 02:11:07 EST</pubDate>
	 <guid isPermaLink="false">news241927215</guid>
	 
</item>
<item>
     <title>Pharma giants open up drug patents in new collaboration</title>
   	 <description> Pharmaceutical giants and the UN intellectual property agency launched Wednesday a collaboration to share certain patented drug information with public organisations.</description>
     <link>http://medicalxpress.com/news/2011-10-pharma-giants-drug-patents-collaboration.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 26 Oct 2011 11:12:40 EST</pubDate>
	 <guid isPermaLink="false">news238846347</guid>
	 
</item>
<item>
     <title>US approves new drug against skin cancer</title>
   	 <description> A breakthrough drug that could extend survival in some patients with advanced skin cancer was approved on Wednesday by US regulators, offering the first new treatment for melanoma in 13 years.</description>
     <link>http://medicalxpress.com/news/2011-08-roche-drug-late-stage-melanoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 17 Aug 2011 11:33:17 EST</pubDate>
	 <guid isPermaLink="false">news232799580</guid>
	 
</item>
<item>
     <title>Rutgers laboratory helped to create new HIV drug</title>
   	 <description>Two decades after a Rutgers team began working with legendary drug developer Paul Janssen, founder of a Belgian subsidiary of pharmaceutical giant Johnson &amp; Johnson in an effort to create new and potent drugs to fight AIDS, the U.S. Food and Drug Administration has approved the second anti-HIV drug that came from this collaboration.</description>
     <link>http://medicalxpress.com/news/2011-06-rutgers-laboratory-hiv-drug.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 23 Jun 2011 13:29:34 EST</pubDate>
	 <guid isPermaLink="false">news228054561</guid>
	 
</item>


</channel>
</rss>
